1.        Auvin S, Bellavoine V, Merdariu D, Delanoë C, Elmaleh-Bergés M, Gressens P, et al. Hemiconvulsion-hemiplegia-epilepsy syndrome: current understandings. Eur J Paediatr Neurol. 2012;16(5):413-21. doi: 10.1016/j.ejpn.2012.01.007.

2.        Beaumanoir A, Blume W. The Lennox-Gastaut syndrome. In: Roger J, Bureau M, Dravet CH, Genton P, Tassinari CA,Wolf P, eds. Epileptic syndromes in infancy, childhood and adolescence. 4th ed. London: John Libbey Eurotext Ltd.; 2005. p.125-48.

3.        Bharani S, Trivedi C, Shendurnikar N, Gandhi Dj. Landau Kleffner syndrome. Indian j pediatr. 2001;68(6):567-9.

4.        Burgess R, Wang S, McTague A, Boysen KE, Yang x, zeng Q, et al. The Genetic Landscape of Epilepsy of Infancy with Migrating Focal Seizures. Ann Neurol. 2019;86(6):821-31. doi: 10.1002/ana.25619. Erratum in: Ann Neurol. 2020;87(4):658.

5.        Caraballo RH, Fontana E, Darra F, Cassar L, Negrini F, Fiorini E, et al. Migrating focal seizures in infancy: analysis of the electroclinical pat-terns in 17 patients. J Child Neurol. 2008;23(5):497-506. doi: 10.1177/0883073807309771.

6.        Caraballo RH, Veggiotti P, Kaltenmeier MC, Piazza E, Gamboni B, LopezmAvaria MF, et al. Encephalopathy with status epilepticus during sleep or continuous spikes and waves during slow sleep syndrome: a multicenter, longterm follow-up study of 117 patients. Epilepsy Res. 2013;105(1-2):164-73. doi: 10.1016/j.eplepsyres.2013.02.010.

7.        Cetica V, Chiari S, Mei D, Parrini E, Grisotto L, Marini C, et al. Clinical and genetic factors predicting Dravet syndrome in infants with SCN1A mutations. Neurology. 2017;88(11):1037-44. doi: 10.1212/WNL.0000000000003716.

8.        Coppola G, Plouin P, Chiron C, Robain O, Dulac O. Migrating partial seizures in infancy: a malignant epilepsy with developmental arrest. Epilepsia. 1995;36(10):1017 1024.

9.        Dravet C, Bureau M, Oguni H, Çokar O, Guerrini R. Dravet syndrome (previously severe myoclonic epilepsy in infancy). In: Bureau M, Genton G, Dravet C, Delgado-Escueta AV, Guerrini R, Tassinari CA, et al., eds. Epileptic Syndromes in Infancy, Childhood and Adolescence. 6th ed. France: John Libbey Eurotext; 2019 :p.139-172.

10.     Farias-Moeller R, Bartolini L, Staso K, Schreiber JM, Carpenter JL. Early ictal and interictal patterns in FIRES: The sparks before the blaze. Epilepsia. 2017; 58(8):1340-8. doi: 10.1111/epi.13801.

11.     Guerrini R, Dobyns WB. Malformations of cortical development: Clinical features and genetic causes. Lancet Neurol. 2014;13(7):710-726.

12.     Guerrini R, Parmeggiani I, Kaminska A, Dulac O. Myoclonic astatic epilepsy. In: Roger J, Bureau M, Dravet CH, Genton P, Tassinari CA, Wolf P, eds. Epileptic Syndromes in Infancy, Childhood and Adolescence. 3rd ed. London: John Libbey; 2002. p.105-12.

13.     Guerrini R, Parrini E. Epileptic encephalopathies with early onset. Semin Neurol. 2012;32(4):371-379.

14.     Guerrini R, Striano P, Catarino C, Sisodiya SM. Neuroimaging and neuropathology of Dravet syndrome. Epilepsia. 2011;52 Suppl 2:30-4. doi: 10.1111/j.1528-1167.2011.02998.x.

15.     How should children with epileptic encephalopathies be evaluated? Epilepsia. 2017;58 Suppl 4:15-24.

16.     Hrachovy RA, Frost JD Jr. Infantile epileptic encephalopathy with hypsarrhythmia (infantile spasms/West syndrome). J Clin Neurophysiol. 2003; 20(6):408-25. doi: 10.1097/00004691-200311000-00004.

17.     Infantile spasms syndrome. In: Epilepsies in children, young people and adults. Natio nal Institute for Health and Care Excellence (NICE) guideline [NG217]. [cited: August 08, 2023]. Available from: https://www.nic e.org.uk/guidance/ng217/chapter/6-Treating-childhood-onset-epilepsies#infantile- spasms-syndrome

18.     Irwin K, Birch v, Lees j, polkey C, Alarcon G,Binnie C, et al. Multiple subpial transection in Landau-Kleffner syndrome. Dev Med Child Neurol. 2001;43(4):248-52.

19.     infection-related epilepsy syndrome. Dev Med Child Neurol. 2020;62(8):897- 905. doi: 10.1111/dmcn.14553.

20.     Kaminska A, Oguni H. Lennox-Gastaut syndrome and epilepsy with myoclonic- astatic seizures. Handb Clin Neurol. 2013;111:641-52. doi: 10.1016/B978-0-444-52891-9.00067-1.

21.     Kersbergen KJ, de Vries LS, Leijten FS, Braun KP, Nievelstein RA, Groenendaal F, et al. Neonatal thalamic hemorrhage is strongly associated with electrical status epilepticus in slow wave sleep. Epilepsia. 2013;54(4):733- 40. doi: 10.1111/epi.12131.

22.     Kramer U, Chi CS, Lin KL, Specchio N, Sahin M, Olson H, et al. Febrile infection- related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome: a multicenter study on 77 children. Epilepsia. 2011;52(11):1956-65. doi: 10.1111/j.1528-1167.2011.03250.x.

23.     Lagae L, Schoonjans AS, Gammaitoni AR, Galer BS, Ceule¬mans B. A pilot, open-label study of the effectiveness and tolerability of lowdose zX008 (fenfluramine HCl) in Lennox- Gastaut syndrome. Epilepsia. 2018; 59:1881-8.

24.     Lam J, Tomaszewski P, Gilbert G, Moreau JT, Guiot MC, Albrecht S, et al. The utility of arterial spin labeling in the presurgical evaluation of poorly defined focal epilepsy in children. J Neurosurg Pediatr. 2020;27(3):243-52. doi: 10.3171/2020.7.PEDS20397.

25.     Lee HF, Chi CS. Febrile infection-related epilepsy syndrome (FIRES): therapeutic complications, long-term neurological and neuroimaging follow-up. Seizure. 2018;56:53-9. doi: 10.1016/j.seizure.2018.02.003.

26.     Lemke JR, Lal D, Reinthaler EM, Steiner I, Nothnagel M, Alber M, et al. Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes. Nat Genet. 2013;45(9):1067-72. doi: 10.1038/ng.2728.

27.     Lesca G, Rudolf G, Bruneau N, Lozovaya N, Labalme A, Boutry-Kryza N, et al. GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunction. Nat Genet. 2013;45(9):1061-6. doi: 10.1038/ng.2726.

28.     Lin Z, Sang T, Yang Y, Wu Y, Dong Y, Ji T, et al. Efficacy of anti-seizure medications, quinidine, and ketogenic diet therapy for KCNT1-related epilepsy and genotype-efficacy correlation analysis. Front Neurol. 2022;12:834971. doi:10.3389/fneur.2021.834971.

29.     McTague A, Appleton R, Avula S, Cross JH, King MD, Jacques TS, et al. Migrating partial seizures of infancy: expansion of the electroclinical, radiological and pathological disease spectrum. Brain. 2013;136(Pt 5):1578-91. doi: 10.1093/brain/awt073.

30.     McTague A, Howell KB, Cross JH, Kurian MA, Scheffer IE. The genetic landscape of the epileptic encephalopathies of infancy and childhood. Lancet Neurol. 2016;15(3):304-316.

31.     Merdariu D, Delanoë C, Mahfoufi N, Bellavoine V, Auvin S. Malignant migrating partial seizures of infancy controlled by stiripentol and clonazepam. Brain Dev. 2013;35(2):177-180. doi:10.1016/j.braindev.2012.03.016.

32.     Mizrahi EM, Kellaway P. Diagnosis and management of neonatal seizures. Lippincott Williams & Wilkins; 1998. p. 73-92.

33.     Myers CT, Hollingsworth G, Muir AM, Schneider AL, Thuesmunn z, Knupp A, et al. Parental Mosaicism in "De Novo" Epileptic Encephalopathies. N Engl J Med. 2018;378(17):1646-8. doi: 10.1056/NEJMc1714579

34.     O'Callaghan FJ, Lux AL, Darke K, Edwards SW, Hancock E, Johnson AL, et al. The effect of lead time to treatment and of age of onset on developmental outcome at 4 years in infantile spasms: evidence from the United Kingdom Infantile Spasms Study. Epilepsia. 2011;52(7):1359-64. doi: 10.1111/j.1528- 1167.2011.03127.x.

35.     Ohtahara S, Yamatogi Y, Ohtsuka Y. Early epileptic encephalopathies. In: Wallace SJ, Farrell K, eds. Epilepsy in Children. London: Arnold; 2004. p.133- 41.

36.     Ohtahara S, Yamatogi Y. Epileptic encephalopathies in early infancy with suppression-burst. J Clin Neurophysiol. 2003;20(6):398-407.

37.     Olson HE, Kelly M, LaCoursiere CM, Pinsky R, Tambunan D, Shain C, et al. Genetics and genotype-phenotype correlations in early onset epileptic encephalopathy with burst suppression. Ann Neurol. 2017;81(3):419-429. doi:10.1002/ana.24883.

38.     Panayiotopoulos CP. Epileptic encephalopathies in infancy and early childhood. The epilepsies: Seizures, Syndromes and Management. Oxfordshire: Bladon Medical Publishing; 2005. p.137-206.

39.     Pellock JM, Hrachovy R, Shinnar S, Baram TZ, Bettis D, Dlugos DJ, et al. Infantile spasms: a U.S. consensus report. Epilepsia. 2010;51(10):2175-2189. doi:10.1111/j.1528-1167.2010.02657.x.

40.     Pressler RM, Cilio MR, Mizrahi EM, Moshé SL, Nunes ML, Plouin P, et al. The ILAE classification of seizures and the epilepsies: Modification for seizures in the neonate. Position paper by the ILAE Task Force on Neonatal Seizures. Epilepsia. 2021;62(3):615-628. doi:10.1111/epi.16815.

41.     Riikonen R. Epidemiological data of West syndrome in Finland. Brain Dev. 2001;23(7):539-41. doi: 10.1016/s0387-7604(01)00263-7.

42.     Riikonen R. Infantile Spasms: Outcome in Clinical Studies. Pediatr Neurol. 2020;108:54-64. doi: 10.1016/j.pediatrneurol.2020.01.015.

43.     Sands TT, Gelinas JN. Epilepsy and encephalopathy. Pediatr Neurol. 2024;150:24-31. doi:10.1016/j.pediatrneurol.2023.09.019.

44.     Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):512-521.

45.     Smith L, Malinowski J, Ceulemans S, Peck K, Walton N, Sheidley BR, et al. Genetic testing and counseling for the unexplained epilepsies: An evidencebased practice guideline of the National Society of Genetic Counselors. J Genet Couns. 2023;32(2):266-80. doi: 10.1002/jgc4.1646.

46.     Specchio N, Wirrell EC, Scheffer IE, et al. International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood. Epilepsia. 2022;63:1398-1442.

47.     Symonds JD, Zuberi SM, Stewart K, McLellan A, O'Regan M, MacLeod S, et al.nIncidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort. Brain. 2019;142(8):2303-2318. doi:10.1093/brain/awz195.

48.     Symonds JD, zuberi SM, Stewart K, McLellan A, O'Regan M, MacLeod S, et al. Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort. rain. 2019;142(8):2303-18. doi: 10.1093/brain/awz195.

49.     Tang S, Pal DK. Dissecting the genetic basis of myoclonic-astatic epilepsy. Epilepsia. 2012;53(8):1303-13. doi: 10.1111/j.1528-1167.2012.03581.x.

50.     Toldo I, Calderone M, Boniver C, Dravet Ch, Guerrini R, Laverda AM. Hemiconvulsion- hemiplegia-epilepsy syndrome: early magnetic resonance imaging findings and neuroradiological follow-up. Brain Dev. 2007;29(2):109-11. doi: 10.1016/j.braindev.2006.06.005.

51.     van den Munckhof B, Alderweireld C, Davelaar S, et al. Treatment of electrical status epilepticus in sleep: Clinical and EEG characteristics and response to 147 treatments in 47 patients. Eur j Paediatr Neurol. 2018;22:64- 71.

52.     Wirrell EC, Nabbout R, Scheffer IE, Alsaadi T, Bogacz A, French JA, et al. Methodology for classification and definition of epilepsy syndromes with list of syndromes: Report of the ILAE Task Force on Nosology and Definitions. Epilepsia. 2022;63(6):1333-1348. doi:10.1111/epi.17237.

53.     Wirrell EC, Shellhaas RA, Joshi C, et al.

54.     Wolff M, Johannesen KM, Hedrich UBS, Masnada S, Rubboli G, Gardella E, et al. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders. Brain. 2017;140(5):1316-36. doi: 10.1093/brain/awx054.

55.     Wong M, Trevathan E. Infantile spasms. Pediatr Neurol. 2001;24(2):89-98. doi:10.1016/S0887-8994(00)00238-1.

56.     Yuskaitis CJ, Ruzhnikov MR, Howell KB, Allen IE, Kapur K, Dlugos DJ, et al. Infantile spasms of unknown cause: predictors of outcome and genotype-phenotype correlation. Pediatr Neurol. 2018;87:48-56. doi:10.1016/j.pediatrneurol.2018.04.012.

57.     Zuberi SM, Wirrell EC, Yozawitz EG, Wilmshurst JM, Specchio N, Riney K, et al. ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and Definitions. Epilepsia. 2022;63(6):1349-1397. doi:10.1111/epi.17239.